Massachusetts Financial Services
MRNA icon

Massachusetts Financial Services’s Moderna MRNA Stock Holding History

Massachusetts Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,102
Closed -$1.86M – 857
2023
Q1 		$1.86M Buy
12,102
+7,627
+170% +$1.26M ﹤0.01% 719
2022
Q4 		$804K Sell
4,475
-38,352
-90% -$6.27M ﹤0.01% 792
2022
Q3 		$5.06M Buy
42,827
+10,793
+34% +$1.64M ﹤0.01% 652
2022
Q2 		$4.58M Sell
32,034
-17,370
-35% -$2.48M ﹤0.01% 658
2022
Q1 		$8.51M Buy
49,404
+22,543
+84% +$3.8M ﹤0.01% 651
2021
Q4 		$6.82M Buy
26,861
+8,781
+49% +$2.57M ﹤0.01% 684
2021
Q3 		$6.96M Buy
18,080
+5,323
+42% +$1.96M ﹤0.01% 691
2021
Q2 		$3M Buy
12,757
+3,335
+35% +$596K ﹤0.01% 741
2021
Q1 		$1.23M Buy
+9,422
New +$1.37M ﹤0.01% 822

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services's MRNA Position: Q2 2023 in Review

Massachusetts Financial Services sold out of Moderna (MRNA) in Q2 2023, closing a stake of 12,102 shares — an estimated $1.86M sold.

Massachusetts Financial Services first reported a position in MRNA in Q1 2021 and held it in 9 quarters. The position peaked at $8.51M in Q1 2022. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Massachusetts Financial Services reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Massachusetts Financial Services sold 12,102 Moderna shares in Q2 2023, an estimated $1.86M.
  • Massachusetts Financial Services first reported a position in Moderna in Q1 2021 and held it in 9 quarters.
  • Massachusetts Financial Services's Moderna position peaked at $8.51M in Q1 2022.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Massachusetts Financial Services's 13F filing for Q2 2023, filed 9 Aug 2023.